EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
12.25
-0.61 (-4.74%)
At close: Jul 31, 2026, 4:00 PM EDT
12.24
-0.01 (-0.08%)
After-hours: Jul 31, 2026, 7:34 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $1.03 billion as of July 31, 2026. Its market cap has increased by 51.68% in one year.
Market Cap
1.03B
Enterprise Value
826.82M
1-Year Change
51.68%
Ranking
Category
Stock Price
$12.25
ChartMarket Cap Chart
Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $1.03B, an increase of 164.30%. That is a compound annual growth rate of 4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.03B | -32.09% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 1.10B |
| MeiraGTx Holdings | 1.09B |
| Wave Life Sciences | 1.09B |
| Alpha Tau Medical | 1.06B |
| Alto Neuroscience | 1.05B |
| Inventiva | 1.03B |
| Lexicon Pharmaceuticals | 1.03B |
| Cullinan Therapeutics | 1.01B |